🎁 Black Friday: up to 50% off of annual plans
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,410.00
-75.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST

NeoImmuneTech Revenue

NeoImmuneTech had revenue of 4.88B KRW in the quarter ending September 30, 2026, with 26,541.51% growth. This brings the company's total for the last twelve months to 6.60B, up 6,902.30% year-over-year. In the year 2025, NeoImmuneTech had annual revenue of 94.82M, down -44.35%. That makes NeoImmuneTech the 40,110th largest company in the world by revenue and 2,491st in South Korea.

Revenue (ttm)
6.60B
Revenue Growth
+6,902.30%
P/S Ratio
21.11
Revenue / Employee
126.97M
Employees
42
Market Cap
139.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202594.82M-75.56M-44.35%
Dec 31, 2024170.38M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bioneer345.88B
GC Cell162.00B
HLB Therapeutics64.45B
GC Genome32.64B
Anterogen.Co.,Ltd.9.29B
Genexine5.81B
iNtRON Biotechnology5.74B
MedPacto4.80B
Revenue Rankings

NeoImmuneTech News

More News